Feed/Investors/Newpath Partners

Newpath Partners

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-05-14

ROUNDS

as lead investor

LED ROUNDS · USD

$40.7M

across 1 round · 1 co-led, split evenly

LATEST ROUND

Series B · $122M · 2026-05-14

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
CREATE Medicines Create Medicines develops innovative immune programming therapies for treating cancer and autoimmune diseases.	Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$122M	2026-05-14	[ LEAD ]